XML 16 R4.htm IDEA: XBRL DOCUMENT v3.20.4
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]        
Net sales $ 1,352.1 $ 1,287.4 $ 3,971.3 $ 3,947.8
Cost of sales 506.3 501.9 1,519.3 1,519.6
Gross profit 845.8 785.5 2,452.0 2,428.2
Research and development 210.1 217.1 607.9 656.0
Selling, general and administrative 154.2 170.7 445.2 510.9
Amortization of acquired intangible assets 231.6 248.7 699.9 745.4
Special charges and other, net 4.3 17.8 8.9 29.5
Operating expenses 600.2 654.3 1,761.9 1,941.8
Operating income 245.6 131.2 690.1 486.4
Other income (expense):        
Interest income 0.2 0.6 0.8 2.3
Interest expense (86.5) (119.7) (278.9) (381.9)
Loss on settlement of debt (142.1) 0.0 (214.0) (2.0)
Other loss, net (0.4) (1.5) (2.9) (0.2)
Income before income taxes 16.8 10.6 195.1 104.6
Income tax benefit (19.4) (300.5) (38.3) (366.1)
Net income $ 36.2 $ 311.1 $ 233.4 $ 470.7
Basic net income per common share (in dollars per share) $ 0.14 $ 1.30 $ 0.91 $ 1.97
Diluted net income per common share (in dollars per share) 0.13 1.20 0.87 1.84
Dividends declared per common share (in dollars per share) $ 0.3685 $ 0.3665 $ 1.1040 $ 1.0980
Basic common shares outstanding (in shares) 263.4 239.2 255.7 238.5
Diluted common shares outstanding (in shares) 275.4 258.3 267.0 255.8